NASDAQ:CHEK Check-Cap - CHEK Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $1.32 +0.01 (+0.76%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.22▼$1.3550-Day Range$1.30▼$5.7852-Week Range$1.22▼$9.20Volume91,213 shsAverage VolumeN/AMarket Capitalization$6.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Check-Cap MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.48% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.24Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.73) to ($2.75) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.31 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Check-Cap. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.48% of the float of Check-Cap has been sold short.Short Interest Ratio / Days to CoverCheck-Cap has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Check-Cap has recently increased by 9.77%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCheck-Cap does not currently pay a dividend.Dividend GrowthCheck-Cap does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CHEK. Previous Next 2.4 News and Social Media Coverage News SentimentCheck-Cap has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Check-Cap this week, compared to 3 articles on an average week.MarketBeat Follows5 people have added Check-Cap to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Check-Cap insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.48% of the stock of Check-Cap is held by insiders.Percentage Held by InstitutionsOnly 17.59% of the stock of Check-Cap is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Check-Cap are expected to grow in the coming year, from ($3.73) to ($2.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Check-Cap is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Check-Cap is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCheck-Cap has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Check-Cap (NASDAQ:CHEK) StockCheck-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.Read More Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEK Stock News HeadlinesMarch 24, 2023 | americanbankingnews.comCheck-Cap (NASDAQ:CHEK) Now Covered by StockNews.comMarch 21, 2023 | finance.yahoo.comCheck-Cap Issues an Update to ShareholdersMarch 25, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...March 21, 2023 | finance.yahoo.comWhy Are Check-Cap Shares Plummeting Today?March 17, 2023 | americanbankingnews.comCheck-Cap (NASDAQ:CHEK) Now Covered by Analysts at StockNews.comMarch 17, 2023 | americanbankingnews.comCheck-Cap Ltd. (NASDAQ:CHEK) Short Interest Up 9.8% in FebruaryNovember 30, 2022 | finance.yahoo.comCheck-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate UpdateOctober 20, 2022 | bbc.comFact-checking Liz Truss at PMQs - BBCMarch 25, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...October 20, 2022 | bloomberg.comGermany's Scholz Warns EU Gas-Price Cap Could Crimp Supplies - BloombergOctober 19, 2022 | globenewswire.comGlobal Smart Pills Market size to record 11.4% CAGR through 2028 - GlobeNewswireOctober 18, 2022 | cnbc.comHere's what you need to know about 2023 Medicare prescription drug plans during open enrollment - CNBCOctober 18, 2022 | bloomberg.comRussia Won't Sell Price-Capped Crude. Period - BloombergOctober 18, 2022 | washingtonpost.comGOP to use debt limit to force spending cuts, with Medicare, Social Security in mix, McCarthy says - The Washington PostOctober 18, 2022 | forbes.comAmerican Airlines To Pay At Least $7.5 Million In Lawsuit Over Baggage Fees - ForbesOctober 18, 2022 | marketwatch.comThe Best Home Warranty Companies in Wyoming - MarketWatchOctober 17, 2022 | washingtonpost.comAmerican Airlines agrees to pay at least $7.5 million in bag-fee case - The Washington PostOctober 16, 2022 | fool.comHow Big Will Warren Buffett's Social Security Check Be After the Monster Increase? - The Motley FoolOctober 15, 2022 | cnet.comTime Is Almost Out to Receive Illinois Income and Property Tax Rebates - CNETOctober 15, 2022 | finance.yahoo.comDo You Think Ferguson plc (FERG) can Deliver Attractive Results in the Future? - Yahoo FinanceOctober 14, 2022 | abcnews.go.comAbbott launches new infant formula recall at another plant for faulty bottle cap seals - ABC NewsOctober 14, 2022 | cnbc.comYou may have ‘more money than ever’ left in a health FSA this year. What you need to know before pandemic relief expires - CNBCOctober 10, 2022 | finance.yahoo.comShould You Consider Investing in Global Industrial Company (GIC)? - Yahoo FinanceOctober 10, 2022 | finance.yahoo.comHere’s Why Vericel Corporation (VCEL) Shares Declined in the Second Quarter - Yahoo FinanceOctober 10, 2022 | apnews.comUmps check Padres pitcher Musgrove's ears for sticky stuff - The Associated Press - en EspañolOctober 10, 2022 | usnews.comUmps Check Padres Pitcher Musgrove's Ears for Sticky Stuff - U.S. News & World ReportOctober 8, 2022 | cnet.comState Stimulus Checks 2022: These States Are Mailing out Payments This Week - CNETSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEK Company Calendar Last Earnings11/03/2021Today3/25/2023Next Earnings (Estimated)4/06/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry X - ray apparatus & tubes Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CHEK CUSIPN/A CIK1610590 Webwww.check-cap.com Phone972546706451Fax972-4821-1267Employees65Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,200,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-41.95% Return on Assets-38.14% Debt Debt-to-Equity RatioN/A Current Ratio12.14 Quick Ratio12.14 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.52 per share Price / Book0.13Miscellaneous Outstanding Shares4,820,000Free Float4,798,000Market Cap$6.36 million OptionableNot Optionable BetaN/A Key ExecutivesAlex OvadiaChief Executive OfficerJoshua BelkarVice President-OperationsMira RosenzweigChief Financial OfficerYoav KimchyChief Technology OfficerBoaz ShpigelmanVice President-Research & DevelopmentKey CompetitorsAileron TherapeuticsNASDAQ:ALRNDynatronicsNASDAQ:DYNTNeuBase TherapeuticsNASDAQ:NBSEKintara TherapeuticsNASDAQ:KTRAIMVNASDAQ:IMVView All CompetitorsInstitutional OwnershipJane Street Group LLCSold 23,512 shares on 2/15/2023Ownership: 0.557%View All Institutional Transactions CHEK Stock - Frequently Asked Questions Should I buy or sell Check-Cap stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks. How have CHEK shares performed in 2023? Check-Cap's stock was trading at $2.20 at the start of the year. Since then, CHEK shares have decreased by 40.0% and is now trading at $1.32. View the best growth stocks for 2023 here. When is Check-Cap's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 6th 2023. View our CHEK earnings forecast. How were Check-Cap's earnings last quarter? Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Wednesday, November, 3rd. The medical research company reported ($0.80) earnings per share for the quarter, beating analysts' consensus estimates of ($1.00) by $0.20. When did Check-Cap's stock split? Check-Cap's stock reverse split before market open on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Check-Cap own? Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV). When did Check-Cap IPO? (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager. What is Check-Cap's stock symbol? Check-Cap trades on the NASDAQ under the ticker symbol "CHEK." Who are Check-Cap's major shareholders? Check-Cap's stock is owned by many different retail and institutional investors. Top institutional investors include Jane Street Group LLC (0.56%). How do I buy shares of Check-Cap? Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Check-Cap's stock price today? One share of CHEK stock can currently be purchased for approximately $1.32. How much money does Check-Cap make? Check-Cap (NASDAQ:CHEK) has a market capitalization of $6.36 million. The medical research company earns $-17,200,000.00 in net income (profit) each year or ($3.24) on an earnings per share basis. How can I contact Check-Cap? Check-Cap's mailing address is 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000. The official website for the company is www.check-cap.com. The medical research company can be reached via phone at 972546706451, via email at jeremy@lifesciadvisors.com, or via fax at 972-4821-1267. This page (NASDAQ:CHEK) was last updated on 3/25/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.